Logo image of CFLT

CONFLUENT INC-CLASS A (CFLT) Stock Fundamental Analysis

NASDAQ:CFLT - US20717M1036 - Common Stock

17.725 USD
+0.45 (+2.58%)
Last: 8/22/2025, 11:15:02 AM
Fundamental Rating

4

Taking everything into account, CFLT scores 4 out of 10 in our fundamental rating. CFLT was compared to 283 industry peers in the Software industry. The financial health of CFLT is average, but there are quite some concerns on its profitability. CFLT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CFLT had positive earnings in the past year.
CFLT had a positive operating cash flow in the past year.
CFLT had negative earnings in each of the past 5 years.
In the past 5 years CFLT reported 4 times negative operating cash flow.
CFLT Yearly Net Income VS EBIT VS OCF VS FCFCFLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

CFLT has a Return On Assets of -11.06%. This is in the lower half of the industry: CFLT underperforms 61.13% of its industry peers.
CFLT has a Return On Equity of -29.31%. This is in the lower half of the industry: CFLT underperforms 61.13% of its industry peers.
Industry RankSector Rank
ROA -11.06%
ROE -29.31%
ROIC N/A
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
CFLT Yearly ROA, ROE, ROICCFLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CFLT's Gross Margin of 74.22% is fine compared to the rest of the industry. CFLT outperforms 63.25% of its industry peers.
In the last couple of years the Gross Margin of CFLT has grown nicely.
The Profit Margin and Operating Margin are not available for CFLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
CFLT Yearly Profit, Operating, Gross MarginsCFLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFLT has been increased compared to 1 year ago.
CFLT has more shares outstanding than it did 5 years ago.
CFLT has a better debt/assets ratio than last year.
CFLT Yearly Shares OutstandingCFLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CFLT Yearly Total Debt VS Total AssetsCFLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CFLT has an Altman-Z score of 1.67. This is a bad value and indicates that CFLT is not financially healthy and even has some risk of bankruptcy.
CFLT has a Altman-Z score of 1.67. This is comparable to the rest of the industry: CFLT outperforms 43.11% of its industry peers.
CFLT has a debt to FCF ratio of 66.29. This is a negative value and a sign of low solvency as CFLT would need 66.29 years to pay back of all of its debts.
With a Debt to FCF ratio value of 66.29, CFLT perfoms like the industry average, outperforming 47.70% of the companies in the same industry.
CFLT has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
CFLT has a Debt to Equity ratio of 1.03. This is in the lower half of the industry: CFLT underperforms 74.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 66.29
Altman-Z 1.67
ROIC/WACCN/A
WACC11.02%
CFLT Yearly LT Debt VS Equity VS FCFCFLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CFLT has a Current Ratio of 3.98. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
CFLT has a better Current ratio (3.98) than 83.04% of its industry peers.
CFLT has a Quick Ratio of 3.98. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CFLT (3.98) is better than 83.04% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
CFLT Yearly Current Assets VS Current LiabilitesCFLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

CFLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.64%, which is quite impressive.
CFLT shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.01%.
The Revenue has been growing by 45.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)23.01%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%20.13%

3.2 Future

Based on estimates for the next years, CFLT will show a very strong growth in Earnings Per Share. The EPS will grow by 29.71% on average per year.
CFLT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.07% yearly.
EPS Next Y23.49%
EPS Next 2Y27.34%
EPS Next 3Y31.6%
EPS Next 5Y29.71%
Revenue Next Year19.67%
Revenue Next 2Y19.01%
Revenue Next 3Y19.1%
Revenue Next 5Y17.07%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CFLT Yearly Revenue VS EstimatesCFLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CFLT Yearly EPS VS EstimatesCFLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.24, the valuation of CFLT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CFLT.
CFLT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.76.
The Price/Forward Earnings ratio is 36.44, which means the current valuation is very expensive for CFLT.
CFLT's Price/Forward Earnings ratio is in line with the industry average.
CFLT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.91.
Industry RankSector Rank
PE 49.24
Fwd PE 36.44
CFLT Price Earnings VS Forward Price EarningsCFLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CFLT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 370.22
EV/EBITDA N/A
CFLT Per share dataCFLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CFLT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CFLT's earnings are expected to grow with 31.60% in the coming years.
PEG (NY)2.1
PEG (5Y)N/A
EPS Next 2Y27.34%
EPS Next 3Y31.6%

0

5. Dividend

5.1 Amount

No dividends for CFLT!.
Industry RankSector Rank
Dividend Yield N/A

CONFLUENT INC-CLASS A

NASDAQ:CFLT (8/22/2025, 11:15:02 AM)

17.725

+0.45 (+2.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners95.66%
Inst Owner Change-3.22%
Ins Owners3.65%
Ins Owner Change17.08%
Market Cap6.11B
Analysts77.95
Price Target26.41 (49%)
Short Float %7.24%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.16%
Min EPS beat(2)5.94%
Max EPS beat(2)16.38%
EPS beat(4)4
Avg EPS beat(4)41.96%
Min EPS beat(4)5.94%
Max EPS beat(4)91.45%
EPS beat(8)8
Avg EPS beat(8)128.74%
EPS beat(12)12
Avg EPS beat(12)102.21%
EPS beat(16)16
Avg EPS beat(16)81.23%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)0.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)0.52%
Revenue beat(8)6
Avg Revenue beat(8)0.33%
Revenue beat(12)10
Avg Revenue beat(12)0.81%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-9.78%
PT rev (3m)-14.33%
EPS NQ rev (1m)1.7%
EPS NQ rev (3m)-3%
EPS NY rev (1m)0%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 49.24
Fwd PE 36.44
P/S 5.74
P/FCF 370.22
P/OCF 146.11
P/B 5.74
P/tB 6.85
EV/EBITDA N/A
EPS(TTM)0.36
EY2.03%
EPS(NY)0.49
Fwd EY2.74%
FCF(TTM)0.05
FCFY0.27%
OCF(TTM)0.12
OCFY0.68%
SpS3.09
BVpS3.09
TBVpS2.59
PEG (NY)2.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.06%
ROE -29.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.22%
FCFM 1.55%
ROA(3y)-16.7%
ROA(5y)-21.68%
ROE(3y)-49.78%
ROE(5y)-55.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 66.29
Debt/EBITDA N/A
Cap/Depr 97.23%
Cap/Sales 2.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z 1.67
F-Score6
WACC11.02%
ROIC/WACCN/A
Cap/Depr(3y)148.98%
Cap/Depr(5y)197.88%
Cap/Sales(3y)2.54%
Cap/Sales(5y)2.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y23.49%
EPS Next 2Y27.34%
EPS Next 3Y31.6%
EPS Next 5Y29.71%
Revenue 1Y (TTM)23.01%
Revenue growth 3Y35.44%
Revenue growth 5Y45.1%
Sales Q2Q%20.13%
Revenue Next Year19.67%
Revenue Next 2Y19.01%
Revenue Next 3Y19.1%
Revenue Next 5Y17.07%
EBIT growth 1Y3.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year376.67%
EBIT Next 3Y129.35%
EBIT Next 5Y86.45%
FCF growth 1Y108.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.81%
OCF growth 3YN/A
OCF growth 5YN/A